• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma

  • — 26 Feb, 2008
AudioMedica News
AudioMedica News
Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma
Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma
00:00 /
RSS Feed
Share
Link
Embed
Martin Dreyling
Martin Dreyling

Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
MARTIN DREYLING, University Hospital Grosshaden, Munich
Since the 1970s therapies for mantle cell lymphoma have greatly extended life, Martin Dreyling told conference delegates in Paris. He gave Peter Goodwin his latest data on combination therapy using the antibody, rituximab, and the emerging rĂ´les of other targeted agents.

Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma



LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/080226_martin_dreyling.mp3]

You may also like...

  • Colorectal Cancer: KRAS-Driven Selection Of Molecular Therapy Could Save Millions: Bevacizumab, Cetuximab, Panitumomab, or Combinations? Colorectal Cancer: KRAS-Driven Selection Of Molecular Therapy Could Save Millions: Bevacizumab, Cetuximab, Panitumomab, or Combinations? 27 Apr, 2009
  • Can these Women with Breast Cancer Avoid Chemotherapy? Can these Women with Breast Cancer Avoid Chemotherapy? 24 Aug, 2016
  • ASCO Audio Journal of Oncology in Advance – June 1st, 2007 – reporting from: American Association for Cancer Research Centennial Meeting, April 14-18, Los Angeles ASCO Audio Journal of Oncology in Advance – June 1st, 2007 – reporting from: American Association for Cancer Research Centennial Meeting, April 14-18, Los Angeles 2 Jun, 2007
  • ASCO Audio Journal of Oncology – June 1st, 2006 – In the company of Gordon McVie ASCO Audio Journal of Oncology – June 1st, 2006 – In the company of Gordon McVie 30 May, 2006
  • Previous story Chronic Lymphocytic Leukemia After Fludarabine Failure
  • Next story “Total Therapy” Possible Cure For Multiple Myeloma?
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • New Front Line Standard for Older Patients with Chronic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Microbiome Diversity Key To Survival After Allogeneic…
    • Which Tasks Most Influence Pediatric PT Productivity,…
  • Home
  • News
  • Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.